Biotech

All Articles

Novo inks $600M NanoVation bargain to examine genetic drugs ex-liver

.Novo Nordisk is continuing its press right into hereditary medications, accepting to pay NanoVation...

Innovent links cytokine to colon cancer cells reactions

.Innovent Biologics has actually helped make the scenario that its checkpoint inhibitor-cytokine ble...

Merck, Daiichi ADC attacks objective in period 3 bronchi cancer research

.A period 3 test of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (...

Rakovina strengthens AI concentrate along with collab to decide on cancer targets

.Five months after Rakovina Therapeutics pivoted toward artificial intelligence, the cancer-focused ...

Ascendis' dwarfism medication hits in period 3, intimidates BioMarin

.Ascendis Pharma has become a potential risk to BioMarin's Voxzogo, mentioning phase 3 growth ailmen...

Despite ph. 3 miss, Alkeus views path in advance for eye health condition asset

.Though Alkeus Pharmaceuticals' dental eye ailment possession failed to dramatically lessen geograph...

Kairos goes social with $6M IPO to finance tests of cancer medicine

.With a triad of biotechs attacking the Nasdaq on Friday, it was actually very easy to miss out on a...

Vaccine as well as Keytruda combination helpful in squamous cell carcinoma

.Immune system gate inhibitors are actually the superheroes of cancer therapy. Drugs like Bristol My...

Cue Biopharma mark time J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of considerable management hirings, shootin...

Regeneron's Opdualag opponent reveals 57% feedback price

.Regeneron is back along with long-lasting follow-up for its own LAG-3 inhibitor and also PD-1 inhib...